Avanos Medical (AVNS) Set to Announce Earnings on Wednesday

Avanos Medical (NYSE:AVNS) is scheduled to announce its earnings results before the market opens on Wednesday, July 31st. Analysts expect the company to announce earnings of $0.29 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Avanos Medical Stock Up 0.9 %

NYSE AVNS traded up $0.21 during trading on Tuesday, reaching $23.09. 51,425 shares of the company’s stock traded hands, compared to its average volume of 245,119. Avanos Medical has a 12-month low of $17.24 and a 12-month high of $24.54. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.28 and a quick ratio of 1.47. The firm has a market cap of $1.06 billion, a price-to-earnings ratio of -17.19 and a beta of 0.94. The company’s 50 day simple moving average is $20.33 and its two-hundred day simple moving average is $19.65.

Analysts Set New Price Targets

AVNS has been the topic of several recent research reports. JMP Securities reaffirmed a “market perform” rating on shares of Avanos Medical in a research report on Tuesday, May 7th. StockNews.com upgraded shares of Avanos Medical from a “hold” rating to a “buy” rating in a report on Saturday, May 11th.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.